These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2420396)

  • 1. [Eosinophilic bodies in the proximal renal tubules of rats given potassium bromate].
    Onodera H; Tanigawa H; Matsushima Y; Maekawa A; Kurokawa Y; Hayashi Y
    Eisei Shikenjo Hokoku; 1985; (103):15-20. PubMed ID: 2420396
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinogenicity of potassium bromate administered orally to F344 rats.
    Kurokawa Y; Hayashi Y; Maekawa A; Takahashi M; Kokubo T; Odashima S
    J Natl Cancer Inst; 1983 Nov; 71(5):965-72. PubMed ID: 6580498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of carcinogenicity of potassium bromate after subcutaneous injection to newborn mice and newborn rats.
    Matsushima Y; Takamura N; Imazawa T; Kurokawa Y; Hayashi Y
    Sci Rep Res Inst Tohoku Univ Med; 1986 Dec; 33(1-4):22-6. PubMed ID: 3629215
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement by potassium bromate of renal tumorigenesis initiated by N-ethyl-N-hydroxyethylnitrosamine in F-344 rats.
    Kurokawa Y; Takahashi M; Kokubo T; Ohno Y; Hayashi Y
    Gan; 1983 Oct; 74(5):607-10. PubMed ID: 6642133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium bromate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1986; 40():207-20. PubMed ID: 3473002
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between the duration of treatment and the incidence of renal cell tumors in male F344 rats administered potassium bromate.
    Kurokawa Y; Matsushima Y; Takamura N; Imazawa T; Hayashi Y
    Jpn J Cancer Res; 1987 Apr; 78(4):358-64. PubMed ID: 3108216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinogenicity of potassium bromate in F-344 rats].
    Ohno Y; Onodera H; Takamura N; Imazawa T; Maekawa A; Kurokawa Y
    Eisei Shikenjo Hokoku; 1982; (100):93-100. PubMed ID: 7183412
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-response studies on the carcinogenicity of potassium bromate in F344 rats after long-term oral administration.
    Kurokawa Y; Aoki S; Matsushima Y; Takamura N; Imazawa T; Hayashi Y
    J Natl Cancer Inst; 1986 Oct; 77(4):977-82. PubMed ID: 3463824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term oral administration of potassium bromate in male Syrian golden hamsters.
    Takamura N; Kurokawa Y; Matsushima Y; Imazawa T; Onodera H; Hayashi Y
    Sci Rep Res Inst Tohoku Univ Med; 1985 Dec; 32(1-4):43-6. PubMed ID: 3837933
    [No Abstract]   [Full Text] [Related]  

  • 10. Workplace environmental exposure level guide: potassium bromate.
    Am Ind Hyg Assoc J; 1981 Mar; 42(3):A53-5. PubMed ID: 6784565
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of brominated proteins and changes in protein expression in the rat kidney with subcarcinogenic to carcinogenic doses of bromate.
    Kolisetty N; Bull RJ; Muralidhara S; Costyn LJ; Delker DA; Guo Z; Cotruvo JA; Fisher JW; Cummings BS
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):391-8. PubMed ID: 23811332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiology of bromate-induced cancer and possible modes of action-studies in Japan.
    Umemura T; Kurokawa Y
    Toxicology; 2006 Apr; 221(2-3):154-7. PubMed ID: 16473452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early appearance and localization of intranuclear inclusions in the segments of renal proximal tubules of rats following ingestion of lead.
    Murakami M; Kawamura R; Nishii S; Katsunuma H
    Br J Exp Pathol; 1983 Apr; 64(2):144-55. PubMed ID: 6303379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid bodies in drug-induced acute tubular necrosis.
    Jao W; Manaligod JR; Gerardo LT; Castillo MM
    J Pathol; 1983 Jan; 139(1):33-40. PubMed ID: 6298392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible participation of oxidative stress in causation of cell proliferation and in vivo mutagenicity in kidneys of gpt delta rats treated with potassium bromate.
    Umemura T; Tasaki M; Kijima A; Okamura T; Inoue T; Ishii Y; Suzuki Y; Masui N; Nohmi T; Nishikawa A
    Toxicology; 2009 Mar; 257(1-2):46-52. PubMed ID: 19133310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biomarkers of oxidative stress associated with bromate carcinogenicity.
    Delker D; Hatch G; Allen J; Crissman B; George M; Geter D; Kilburn S; Moore T; Nelson G; Roop B; Slade R; Swank A; Ward W; DeAngelo A
    Toxicology; 2006 Apr; 221(2-3):158-65. PubMed ID: 16442688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk evaluation of tumor-inducing substances in foods.
    Hayashi Y; Kurokawa Y; Maekawa A
    Princess Takamatsu Symp; 1985; 16():295-303. PubMed ID: 3916202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Observations of autophagosomes in the epithelial cells of a rat kidney proximal tubules (author's transl)].
    Latalski M; Halliop J; Obuchowska D
    Ann Univ Mariae Curie Sklodowska Med; 1974; 29():86-91. PubMed ID: 4377527
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term toxicity and carcinogenicity studies of the bread improver potassium bromate 1. Studies in rats.
    Fisher N; Hutchinson JB; Berry R; Hardy J; Ginocchio AV; Waite V
    Food Cosmet Toxicol; 1979 Feb; 17(1):33-9. PubMed ID: 437610
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of sodium chromate on the proximal tubules of the rat kidney. Fine structural damage and lysozymuria.
    Evan AP; Dail WG
    Lab Invest; 1974 Jun; 30(6):704-15. PubMed ID: 4365167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.